Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Methyl-accepting chemotaxis protein 4 (MCP-4) is a specialized transmembrane receptor found in bacteria, including Escherichia coli (where it is known as Tap) and Borrelia burgdorferi (BB0680). It functions as a sensory transducer that detects environmental chemical signals—such as dipeptides in E. coli—and relays this information to the flagellar motor to direct bacterial movement, a process essential for nutrient acquisition and host colonization [1, 2, 28]. In pathogenic species like Borrelia burgdorferi, the causative agent of Lyme disease, MCP-4 has been identified as a major immunogenic protein that triggers CD4+ T cell responses and contributes to the inflammatory pathology of the disease [7, 14, 20]. While no therapeutic drugs currently target MCP-4, it is an active area of research for the development of anti-virulence therapies and vaccines aimed at preventing bacterial infections by disrupting their ability to navigate and persist within the host [2, 3, 31]. Its role as a specific bacterial antigen also makes it a potential candidate for diagnostic biomarkers in infectious diseases [14, 19].
Inhibition of bacterial chemotaxis and host colonization
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Methyl-accepting chemotaxis protein 4 (MCP-4).